Digipath
Home > Boards > US Listed > Medical - Drugs >

Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

KTOV RSS Feed
Add KTOV Price Alert      Hide Sticky   Hide Intro
Moderator: bUrRpPPP!, finesand
Search This Board: 
Last Post: 1/21/2019 11:05:51 AM - Followers: 125 - Board type: Free - Posts Today: 2




Kitov Pharma (KTOV)

Market Cap: $16 Million
Cash $17 Million
Price: $1.44

Shares Out: 10.6 Million


Kitov Announces FDA Acceptance of NDA for KIT-302..........October 3, 2017
https://www.baystreet.ca/articles/research_reports/lifesci/Kitov100317.pdf

KIT-302 is a Treatment for Hypertension and Osteoarthritis Pain.
KIT-302 is a fixed dose combination drug comprised of the nonsteroidal anti-inflammatory drug (NSAID)celecoxib, and the well-known antihypertensive agent, amlodipine besylate. Celecoxib monotherapy often leads to hypertension, which if uncontrolled, can increase the risk of heart attack and stroke. KIT-302 is designed to provide a solution for physicians who avoid prescribing NSAIDs for osteoarthritis pain due to their hypertensive side effects. There is currently no single drug for the treatment of pain and hypertension, so, if approved, KIT-302 could be a unique product in the multibillion-dollar osteoarthritis market.

Expected Upcoming Milestones

¦Additional marketing agreements for the distribution of KIT-302
¦Q4 2017 – Top-line results from Phase III kidney function trial.
¦Q2 2018 – Expected FDA approval decision for KIT-302.




Presentation June 2017
http://kitovpharma.investorroom.com/download/KitovPresentation+June+2017+FINAL.pdf

KIT-302 is a combination drug that treats osteoarthritis pain and hypertension simultaneously

Primary efficacy endpoint achieved Lead drug candidate KIT-302 achieved its primary efficacy endpoint in a pivotal Phase III trial

Marketing potential Pipeline candidates address large, multi-billion dollar markets




Kitov Received a $2 Million Filing Waiver from FDA
http://kitovpharma.investorroom.com/news-releases?item=46

Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV, TASE: KTOV), an innovative biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted Kitov a waiver related to the $2,038,100 New Drug Application (NDA 210045) filing fee for KIT-302. KIT-302 is Kitov's patented combination of Amlodipine Besylate-Celecoxib tablets, intended to treat osteoarthritis pain and hypertension simultaneously.

 

Products

Kitov’s current pipeline products, KIT-301 and KIT-302, are combination drugs that treat OA pain and HTN simultaneously. In December 2015, KIT-302 successfully achieved the primary efficacy endpoint for its Phase III clinical trial. In August 2016, the United States Patent Office issued a patent covering KIT-302.

Market

Of the 27 million Americans with OA, 50% also suffer from HTN, which is also a common side effect of stand-alone OA drugs. With no single medication currently treating both conditions, KIT-301 and KIT-302 are targeting this multi-billion dollar market.



Kitov Pharma’s Arthritis Drug Meets Main Goal in Late-Stage Study
http://jewishbusinessnews.com/2015/12/16/kitov-pharmas-arthritis-drug-meets-main-goal-in-late-stage-study/

“KIT-302 has the potential to address the multi-billion dollar market for the treatment of osteoarthritis pain and hypertension with one drug that reduces patients’ risk of suffering a heart attack or stroke, while also reducing cost for payers. There is currently no single medication on the market that treats both osteoarthritis pain and hypertension and thus, KIT-302 will be the only NSAID indicated both to treat pain and to reduce the risk of heart attack, stroke and death.”

Pain medications for osteoarthritis account for billions of dollars in annual sales globally. Most pain medications for osteoarthritis, including celecoxib which had global sales of $2.7 billion in 2014, are non-steroidal anti-inflammatory drugs (NSAIDs) which have the side effect of elevating blood pressure, and increasing the risk of heart attacks, strokes and death. Of the 27 million Americans who live with osteoarthritis, 13.5 million also suffer from hypertension, which also increases the risk of heart attack, stroke, and death.





Dec. 17, 2015 :  Kitov Pharmaceuticals Reports Additional Data from its Phase III Trial on the Beneficial Blood Pressure Effects of KIT-302
http://www.prnewswire.com/news-releases/kitov-pharmaceuticals-reports-additional-data-from-its-phase-iii-trial-on-the-beneficial-blood-pressure-effects-of-kit-302-300194664.html



November 20, 2015 : Kitov Pharmaceuticals Holdings Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing
http://www.prnewswire.com/news-releases/kitov-pharmaceuticals-holdings-announces-pricing-of-us-initial-public-offering-and-nasdaq-listing-552301701.html



October 21, 2015 : Kitov Pharma Announces Completion of Patient Recruitment for the Phase III Clinical Trial for KIT-302
http://www.prnewswire.com/news-releases/kitov-pharma-announces-completion-of-patient-recruitment-for-the-phase-iii-clinical-trial-for-kit-302-535035241.html





 

Digipath
KTOV
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KTOV News: Report of Foreign Issuer (6-k) 01/18/2019 05:23:45 PM
KTOV News: Kitov Closes $6 Million Registered Direct Offering 01/18/2019 04:30:00 PM
KTOV News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 01/18/2019 12:05:10 PM
KTOV News: Report of Foreign Issuer (6-k) 01/18/2019 12:00:10 PM
KTOV News: Report of Foreign Issuer (6-k) 01/16/2019 04:07:33 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#6837  Sticky Note Detailed Consensi Valuation Update 3 finesand 01/09/19 03:49:12 AM
#6932   Nice. Volume also decent. Looking forward to tomorrow’s Locke1 01/21/19 11:05:51 AM
#6931   Nice action in TASE/KTOV today. +15.5% now, price midastouch017 01/21/19 07:34:33 AM
#6930   Thanks for playing but you had nothing to Slax 01/19/19 05:57:40 PM
#6929   KTOV buy 1.3400 stocktrademan 01/18/19 12:07:41 PM
#6928   Very thorough SA article published today. :-) midastouch017 01/18/19 01:04:45 AM
#6927   Naw don’t buy this theory it’s much too breezy1 01/18/19 12:33:38 AM
#6926   edited: midas, breezy, et al - it is finesand 01/17/19 04:26:50 PM
#6925   Not sure if you noticed but it was breezy1 01/17/19 02:15:07 PM
#6924   Right you are. Thank you for your clsrification. :-) midastouch017 01/17/19 02:04:37 PM
#6923   Not until the financing closes. Right now nsomniyak 01/17/19 01:30:15 PM
#6922   Not getting your point - many times I Amatuer17 01/17/19 11:45:17 AM
#6921   looks like market has credibility issue with them. jdlamont 01/17/19 11:21:16 AM
#6920   looks like they are used to it after jdlamont 01/17/19 08:56:31 AM
#6919   A17 - Funny to read that from you, finesand 01/17/19 08:31:01 AM
#6918   I would say smart move and quick action. They Amatuer17 01/17/19 08:26:20 AM
#6917   Hi Middas I am like you already a Doubletree 01/17/19 06:24:36 AM
#6916   Life is strange. A few days ago we midastouch017 01/17/19 05:35:37 AM
#6915   Actually the terms did not look all that nsomniyak 01/16/19 11:50:27 PM
#6914   If you don't know that Kitov Announced a fwb 01/16/19 09:34:04 PM
#6913   good luck.... fwb 01/16/19 09:28:58 PM
#6912   Offering for 1.74. Common in these bios. Dollar Bill 01/16/19 07:18:42 PM
#6911   * * $KTOV Video Chart 01-16-2019 * * ClayTrader 01/16/19 04:29:27 PM
#6910   Can anyone please explain to me what in LittleBytor 01/16/19 04:16:33 PM
#6909   no, just for engineering a manipulation based on jdlamont 01/16/19 03:25:50 PM
#6908   Like I said Good Luck fwb 01/16/19 02:59:24 PM
#6907   if it was a scheme to defraud investors-it succeeded!!! jdlamont 01/16/19 02:58:32 PM
#6906   often companies that need money and want to jdlamont 01/16/19 02:54:50 PM
#6905   For What? an Offering? Good luck fwb 01/16/19 02:49:38 PM
#6904   Do you think there were a few sellers fwb 01/16/19 02:35:22 PM
#6903   law suits should be coming soon. jdlamont 01/16/19 02:35:15 PM
#6902   And here is the offering.....well, if it is Locke1 01/16/19 01:58:05 PM
#6901   Way to f up again. Offering zj3001 01/16/19 01:56:59 PM
#6900   Sounds good. I bought KTOV in several batches, Locke1 01/16/19 01:50:50 PM
#6899   Thank you. Not so sure now, however i midastouch017 01/16/19 01:31:16 PM
#6898   Well done! Locke1 01/16/19 12:47:59 PM
#6897   KTOV Moving! Lunch Buyers! Going Green soon IMO. instock58 01/16/19 12:33:59 PM
#6896   I sold some 25% of my holdings in midastouch017 01/16/19 12:16:03 PM
#6895   Seems you are correct Amatuer17 01/16/19 11:12:10 AM
#6894   KTOV UP about 70% yesterday just on east instock58 01/16/19 10:15:07 AM
#6893   Poising for a big rise and loading my boat. Maple tree 01/16/19 10:12:22 AM
#6892   There is definitely brewing here...not to long ago zj3001 01/16/19 09:54:34 AM
#6891   How are you doing this morning? Waiting for Locke1 01/16/19 02:16:14 AM
#6890   It's still going up tomorrow. fwb 01/15/19 11:53:23 PM
#6889   Let’s hope that the volume tomorrow is 1/10th Amatuer17 01/15/19 09:28:48 PM
#6888   And There will be Plenty of Buyers to Buy. fwb 01/15/19 09:21:15 PM
#6887   Or those who bought early today will dump tomorrow Amatuer17 01/15/19 08:53:03 PM
#6886   KTOV SmartMoney: I am with you 1000%....Should be instock58 01/15/19 07:42:41 PM
#6885   Damn. I think she's got more in it amank7 01/15/19 06:15:47 PM
#6884   VOLUME is over 5x the OS and 9X [SMART MONEY] 01/15/19 06:14:25 PM
#6883   i might be the only trader that lost Williambilla 01/15/19 05:21:24 PM
PostSubject